​

Elanco Animal Health (ELAN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ELAN Stock Forecast

Elanco Animal Health (ELAN) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $30.00 and a low of $26.00. This represents a 18.90% increase from the last price of $23.55.

$10 $14 $18 $22 $26 $30 High: $30 Avg: $28 Low: $26 Last Closed Price: $23.55

ELAN Stock Rating

Elanco Animal Health stock's rating consensus is Buy, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (71.43%), 4 Hold (19.05%), 2 Sell (9.52%), and 0 Strong Sell (0.00%).

Buy
Total 21 0 2 4 15 Strong Sell Sell Hold Buy Strong Buy

ELAN Price Target Upside V Benchmarks

TypeNameUpside
StockElanco Animal Health18.90%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.85%

Price Target Trends

1M3M12M
# Anlaysts-213
Avg Price Target-$28.00$27.23
Last Closing Price$23.55$23.55$23.55
Upside/Downside-18.90%15.63%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 264112--17
Aug, 265111--17
Jul, 265111--17
Jun, 265111--17
May, 264112--17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 06, 2026KeyBanc$30.00$26.2214.42%27.39%
Jul 22, 2026Erin WrightMorgan Stanley$26.00$25.701.17%10.40%
May 15, 2026Morgan Stanley$23.00$20.929.94%-2.34%
Feb 25, 2026Steve DechertKeyBanc$29.00$27.136.89%23.14%
Feb 24, 2026Daniel ClarkLeerink Partners$30.00$26.3713.77%27.39%
Jan 29, 2026UBS$30.00$24.1724.12%27.39%
Jan 22, 2026David WestenbergPiper Sandler$30.00$24.3023.46%27.39%
Dec 18, 2025Morgan Stanley$22.00$22.08-0.36%-6.58%
Dec 08, 2025Barclays$30.00$21.6938.31%27.39%
Nov 20, 2025KeyBanc$27.00$21.4625.82%14.65%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 06, 2026KeyBancOverweightOverweighthold
Aug 06, 2026CitigroupBuyBuyhold
Jun 29, 2026Piper SandlerOverweightOverweighthold
Jun 18, 2026Cowen & Co.BuyBuyhold
May 07, 2026CitigroupBuyBuyhold
Apr 15, 2026CitigroupBuyBuyinitialise
Mar 10, 2026UBSBuyBuyhold
Feb 25, 2026KeyBancOverweightOverweighthold
Jan 29, 2026UBSBuyBuyhold
Jan 22, 2026Piper SandlerNeutralOverweightupgrade

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.97$-0.15$-2.50$0.68$-0.47---
Avg Forecast$1.01$1.04$0.92$0.91$0.90$1.05$1.22$1.44
High Forecast$1.02$1.06$0.95$0.92$0.99$2.32$1.49$1.47
Low Forecast$0.99$1.03$0.91$0.90$0.82$0.28$0.86$1.42
Surprise %-196.04%-114.42%-371.74%-25.27%-152.22%---

Revenue Forecast

$4B $4B $5B $5B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.76B$4.41B$4.42B$4.44B$4.71B---
Avg Forecast$4.75B$4.41B$4.39B$4.42B$4.54B$4.75B$5.03B$5.28B
High Forecast$4.79B$4.45B$4.40B$4.44B$4.57B$4.75B$5.04B$5.36B
Low Forecast$4.70B$4.38B$4.38B$4.34B$4.49B$4.75B$5.01B$5.23B
Surprise %0.19%0.03%0.72%0.35%3.82%---

Net Income Forecast

$-2B $-1B $-600M $100M $800M $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-483.00M$-78.00M$-1.23B$338.00M$-232.00M---
Avg Forecast$-378.78M$-141.47M$-1.23B$450.17M$445.93M$639.60M$578.20M$710.55M
High Forecast$-303.02M$-94.52M$-822.50M$455.07M$487.35M$1.14B$732.39M$722.92M
Low Forecast$-454.53M$-188.41M$-1.64B$445.28M$404.50M$137.76M$424.01M$700.70M
Surprise %27.51%-44.86%--24.92%-152.03%---

ELAN Forecast FAQ

Is Elanco Animal Health stock a buy?

Elanco Animal Health stock has a consensus rating of Buy, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 4 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Elanco Animal Health is a favorable investment for most analysts.

What is Elanco Animal Health's price target?

Elanco Animal Health's price target, set by 21 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $26 at the low end to $30 at the high end, suggesting a potential 18.90% change from the previous closing price of $23.55.

How does Elanco Animal Health stock forecast compare to its benchmarks?

Elanco Animal Health's stock forecast shows a 18.90% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (26.85%).

What is the breakdown of analyst ratings for Elanco Animal Health over the past three months?

  • September 2026: 23.53% Strong Buy, 64.71% Buy, 11.76% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 29.41% Strong Buy, 64.71% Buy, 5.88% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 29.41% Strong Buy, 64.71% Buy, 5.88% Hold, 0% Sell, 0% Strong Sell.

What is Elanco Animal Health’s EPS forecast?

Elanco Animal Health's average annual EPS forecast for its fiscal year ending in December 2026 is $1.05, marking a -323.40% decrease from the reported $-0.47 in 2025. Estimates for the following years are $1.22 in 2027, and $1.44 in 2028.

What is Elanco Animal Health’s revenue forecast?

Elanco Animal Health's average annual revenue forecast for its fiscal year ending in December 2026 is $4.75B, reflecting a 0.79% increase from the reported $4.72B in 2025. The forecast for 2027 is $5.03B, and $5.28B for 2028.

What is Elanco Animal Health’s net income forecast?

Elanco Animal Health's net income forecast for the fiscal year ending in December 2026 stands at $639.6M, representing a -375.69% decrease from the reported $-232M in 2025. Projections indicate $578.2M in 2027, and $710.55M in 2028.